Sumitomo Mitsui Ds Asset Management Company, LTD Alnylam Pharmaceuticals, Inc. Transaction History

Sumitomo Mitsui Ds Asset Management Company, LTD

$9.15 Billion
Q3 2024

A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 11,581 shares of ALNY stock, worth $2.73 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

11,581

Previous 12,114 4.4%

Holding current value

$2.73 Million

Previous $2.94 Million 8.22%

% of portfolio

0.03%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$233.81 - $287.01 $124,620 - $152,976	-533 Reduced 4.4%	11,581 $3.19 Million
Q2 2024 Jul 30, 2024	BUY	$143.31 - $247.0 $375,328 - $646,893	2,619 Added 27.58%	12,114 $2.94 Million
Q1 2024 May 02, 2024	SELL	$146.51 - $198.2 $4,102 - $5,549	-28 Reduced 0.29%	9,495 $1.42 Million
Q3 2023 Oct 30, 2023	SELL	$170.77 - $211.65 $4,440 - $5,502	-26 Reduced 0.27%	9,523 $1.69 Million
Q2 2023 Aug 04, 2023	BUY	$185.01 - $212.05 $232,927 - $266,970	1,259 Added 15.19%	9,549 $1.81 Million
Q3 2022 Oct 19, 2022	BUY	$138.54 - $232.0 $163,200 - $273,296	1,178 Added 16.56%	8,290 $1.66 Million
Q1 2022 Apr 19, 2022	SELL	$127.18 - $173.91 $4,324 - $5,912	-34 Reduced 0.48%	7,112 $1.16 Million
Q4 2021 Jan 20, 2022	BUY	$159.56 - $209.29 $190,993 - $250,520	1,197 Added 20.12%	7,146 $1.21 Million
Q3 2021 Oct 15, 2021	SELL	$169.75 - $207.73 $13,580 - $16,618	-80 Reduced 1.33%	5,949 $1.12 Million
Q2 2021 Jul 19, 2021	SELL	$128.63 - $176.89 $3,601 - $4,952	-28 Reduced 0.46%	6,029 $1.02 Million
Q1 2021 May 07, 2021	BUY	$126.83 - $175.69 $253 - $351	2 Added 0.03%	6,057 $855,000
Q2 2020 Aug 12, 2020	BUY	$104.21 - $156.44 $729 - $1,095	7 Added 0.12%	6,055 $896,000
Q1 2020 Apr 21, 2020	BUY	$93.12 - $133.99 $3,259 - $4,689	35 Added 0.58%	6,048 $658,000
Q3 2019 Oct 16, 2019	BUY	$70.9 - $87.82 $127,832 - $158,339	1,803 Added 42.83%	6,013 $483,000
Q2 2019 Aug 13, 2019	SELL	$65.86 - $92.79 $1.04 Million - $1.47 Million	-15,833 Reduced 79.0%	4,210 $305,000
Q1 2019 May 07, 2019	SELL	$72.76 - $93.45 $106,375 - $136,623	-1,462 Reduced 6.8%	20,043 $1.87 Million
Q4 2018 Jan 25, 2019	BUY	$62.67 - $88.33 $132,860 - $187,259	2,120 Added 10.94%	21,505 $1.57 Million
Q3 2018 Oct 15, 2018	SELL	$87.52 - $122.67 $4,113 - $5,765	-47 Reduced 0.24%	19,385 $1.7 Million
Q2 2018 Jul 31, 2018	BUY	$88.31 - $107.8 $1.23 Million - $1.5 Million	13,877 Added 249.81%	19,432 $1.91 Million
Q1 2018 Apr 25, 2018	SELL	$115.92 - $148.54 $7,302 - $9,358	-63 Reduced 1.12%	5,555 $661,000
Q4 2017 Jan 25, 2018	BUY	$114.49 - $139.98 $643,204 - $786,407	5,618	5,618 $713,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.

Account

Sumitomo Mitsui Ds Asset Management Company, LTD Alnylam Pharmaceuticals, Inc. Transaction History